Healthcare Services Group, Inc. Reports Q3 2021 Results
Healthcare Services Group, Inc. (NASDAQ:HCSG) reported Q3 2021 revenue of $415.6 million and net income of $9.5 million, or $0.13 per share. The company declared a quarterly cash dividend of $0.21, marking the 73rd consecutive increase since 2003. CEO Ted Wahl acknowledged challenges from supply chain disruptions and labor shortages, exacerbated by the Delta variant. The company is investing in recruiting and wage increases to stabilize operations. Additionally, Kurt Simmons was appointed to the Board, enhancing governance. Cash outflow from operations was $23.1 million.
- Quarterly revenue of $415.6 million and net income of $9.5 million.
- Declared a quarterly cash dividend of $0.21, the 73rd consecutive increase since 2003.
- Appointment of Kurt Simmons to the Board, enhancing corporate governance.
- Supply chain disruptions and labor shortages negatively affected operations.
- Cash outflow from operations totaled $23.1 million, indicating liquidity challenges.
- Increased costs of services, including a $7.7 million rise in labor costs.
Third Quarter Results
Revenue for the quarter was
Direct cost of services was reported at
Housekeeping & laundry and dining & nutrition segment margins were
Selling, general, and administrative (“SG&A”) was reported at
The Company reported an effective tax rate of
Cash outflow from operations for the quarter was
Dividend & Share Repurchase
The Company’s Board of Directors declared a quarterly cash dividend of
Board of Director Appointment
The Board of Directors of the Company appointed
“We are thrilled to welcome Kurt to our Board of Directors. He is a respected leader and seasoned professional who will undoubtedly bring fresh perspective and insight as we work to fulfill our Vision,” said
“I am honored to be named a Board member for the leading service provider in the healthcare space,” said
Conference Call and Upcoming Events
The Company will host a conference call on
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry, primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the nine months ended
These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.
In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our growth strategies.
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (in thousands, except per share data) |
|||||||||||||||
|
For the Three Months Ended |
|
For the Nine Months Ended |
||||||||||||
|
|
|
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Revenues |
$ |
415,590 |
|
|
$ |
435,947 |
|
|
$ |
1,221,512 |
|
|
$ |
1,337,126 |
|
Operating costs and expenses: |
|
|
|
|
|
|
|
||||||||
Cost of services provided |
364,822 |
|
|
365,443 |
|
|
1,037,852 |
|
|
1,140,116 |
|
||||
Selling, general and administrative |
38,780 |
|
|
37,337 |
|
|
128,818 |
|
|
108,819 |
|
||||
Income from operations |
11,988 |
|
|
33,167 |
|
|
54,842 |
|
|
88,191 |
|
||||
Other income, net: |
|
|
|
|
|
|
|
||||||||
Investment and other income, net |
133 |
|
|
3,965 |
|
|
5,294 |
|
|
6,135 |
|
||||
Income before income taxes |
12,121 |
|
|
37,132 |
|
|
60,136 |
|
|
94,326 |
|
||||
Income tax expense |
2,581 |
|
|
9,488 |
|
|
16,378 |
|
|
23,391 |
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income |
$ |
9,540 |
|
|
$ |
27,644 |
|
|
$ |
43,758 |
|
|
$ |
70,935 |
|
|
|
|
|
|
|
|
|
||||||||
Basic earnings per common share |
$ |
0.13 |
|
|
$ |
0.37 |
|
|
$ |
0.58 |
|
|
$ |
0.95 |
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings per common share |
$ |
0.13 |
|
|
$ |
0.37 |
|
|
$ |
0.58 |
|
|
$ |
0.95 |
|
|
|
|
|
|
|
|
|
||||||||
Cash dividends declared per common share |
$ |
0.21000 |
|
|
$ |
0.20500 |
|
|
$ |
0.62625 |
|
|
$ |
0.61125 |
|
|
|
|
|
|
|
|
|
||||||||
Basic weighted average number of common shares outstanding |
74,943 |
|
|
74,700 |
|
|
74,983 |
|
|
74,684 |
|
||||
|
|
|
|
|
|
|
|
||||||||
Diluted weighted average number of common shares outstanding |
75,076 |
|
|
74,777 |
|
|
75,170 |
|
|
74,768 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands) |
|||||||
|
|
|
|
||||
Cash and cash equivalents |
$ |
79,582 |
|
|
$ |
139,330 |
|
Marketable securities, at fair value |
125,583 |
|
|
125,012 |
|
||
Accounts and notes receivable, net |
289,727 |
|
|
255,474 |
|
||
Other current assets |
71,174 |
|
|
52,587 |
|
||
Total current assets |
566,066 |
|
|
572,403 |
|
||
|
|
|
|
||||
Property and equipment, net |
27,817 |
|
|
26,561 |
|
||
Notes receivable - long-term |
30,651 |
|
|
34,417 |
|
||
|
65,545 |
|
|
51,084 |
|
||
Other intangible assets, net |
17,039 |
|
|
18,187 |
|
||
Deferred compensation funding |
50,711 |
|
|
46,825 |
|
||
Other assets |
35,776 |
|
|
35,554 |
|
||
Total Assets |
$ |
793,605 |
|
|
$ |
785,031 |
|
|
|
|
|
||||
Accrued insurance claims - current |
$ |
24,164 |
|
|
$ |
21,610 |
|
Other current liabilities |
129,692 |
|
|
140,650 |
|
||
Total current liabilities |
153,856 |
|
|
162,260 |
|
||
|
|
|
|
||||
Accrued insurance claims - long-term |
63,135 |
|
|
60,818 |
|
||
Deferred compensation liability |
50,747 |
|
|
46,827 |
|
||
Other non-current liabilities |
45,662 |
|
|
34,665 |
|
||
|
|
|
|
||||
Stockholders' equity |
480,205 |
|
|
480,461 |
|
||
Total Liabilities and Stockholders' Equity |
$ |
793,605 |
|
|
$ |
785,031 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005308/en/
President and Chief Executive Officer
Chief Communications Officer
215-639-4274
investor-relations@hcsgcorp.com
Source:
FAQ
What were the Q3 2021 results for HCSG?
What is the dividend declared by HCSG for Q3 2021?
Who was appointed to the HCSG Board in November 2021?
What challenges did HCSG face in Q3 2021?